Praxis Genesis Financial Statements From 2010 to 2024

MGAFX Fund  USD 20.23  0.13  0.64%   
Praxis Genesis financial statements provide useful quarterly and yearly information to potential Praxis Genesis Growth investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Praxis Genesis financial statements helps investors assess Praxis Genesis' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Praxis Genesis' valuation are summarized below:
Praxis Genesis Growth does not presently have any trending fundamental ratios for analysis.
Check Praxis Genesis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Praxis Genesis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Praxis financial statements analysis is a perfect complement when working with Praxis Genesis Valuation or Volatility modules.
  
This module can also supplement various Praxis Genesis Technical models . Check out the analysis of Praxis Genesis Correlation against competitors.

Praxis Genesis Growth Mutual Fund Price To Book Analysis

Praxis Genesis' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Praxis Genesis Price To Book

    
  2.21 X  
Most of Praxis Genesis' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Praxis Genesis Growth is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

Based on the latest financial disclosure, Praxis Genesis Growth has a Price To Book of 2.21 times. This is much higher than that of the Praxis Mutual Funds family and significantly higher than that of the Allocation--70% to 85% Equity category. The price to book for all United States funds is notably lower than that of the firm.

Praxis Genesis Growth Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Praxis Genesis's current stock value. Our valuation model uses many indicators to compare Praxis Genesis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Praxis Genesis competition to find correlations between indicators driving Praxis Genesis's intrinsic value. More Info.
Praxis Genesis Growth is regarded second largest fund in price to earning among similar funds. It also is regarded second largest fund in price to book among similar funds fabricating about  0.12  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Praxis Genesis Growth is roughly  8.34 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Praxis Genesis' earnings, one of the primary drivers of an investment's value.

About Praxis Genesis Financial Statements

Praxis Genesis investors use historical fundamental indicators, such as Praxis Genesis' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Praxis Genesis. Please read more on our technical analysis and fundamental analysis pages.
The Portfolio, a fund of funds, seeks to achieve its investment objective by investing primarily in Class I shares of underlying Praxis Funds. The Portfolio typically invests approximately 10-30 percent of its total assets in bond funds and 70-90 percent of its total assets in equity funds. In selecting underlying funds, the Adviser analyzes many factors, including the underlying funds investment objectives, total return, and volatility.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Praxis Mutual Fund

Praxis Genesis financial ratios help investors to determine whether Praxis Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Praxis with respect to the benefits of owning Praxis Genesis security.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA